Physician
Nephrology
Dr. Hartmut H. Malluche, MD
|
|
Give Review
Dr. Hartmut H. Malluche practices Nephrology. He over the years received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Elected Member" and "Whos Who in Medicine and Healthcare". Hartmut H. Malluche is a published doctor and has 100 publications published. The lastest was: 'The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats.' Doctor Hartmut H. Malluche, MD is registered with Medicare and accepts Medicare payments.
Publications
- Evaluating bone quality in patients with Chronic kidney disease.
- Low-Energy Fractures without Low T-Scores Characteristic of Osteoporosis: A Possible Bone Matrix Disorder.
- Early Chronic kidney disease-mineral bone disorder stimulates vascular calcification.
- Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee.
- Differences in Bone Quality in Low- and High-Turnover Renal Osteodystrophy.
- Renal osteodystrophy in the first decade of the new millennium: Analysis of 630 bone biopsies in black and white patients.
- Sclerostin and Dickkopf-1 in Renal osteodystrophy.
- Treatment with pyrophosphate inhibits uremic Vascular calcification.
- Renal osteodystrophy in the first decade of the new millennium-analysis of 630 bone biopsies in black and white patients.
- Intact PTH combined with the PTH ratio for diagnosis of bone turnover in dialysis patients: a diagnostic test study.
- Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal Failure.
- Low bone volume--a risk factor for coronary calcifications in hemodialysis patients.
- Bone markers predict cardiovascular events in Chronic kidney disease.
- Effects of treatment of Renal osteodystrophy on bone histology.
- PTH regulation of the human cytomegalovirus immediate-early gene promoter.
- Disturbed synthesis of type II collagen interferes with rate of bone formation and growth and increases bone resorption in transgenic mice.
- Bone biopsy in patients with osteoporosis.
- Opposite effects of calcitriol and paricalcitol on the Parathyroid hormone-(1-84)/large carboxy-terminal-Parathyroid hormone fragments ratio in patients with stage 5 c...
- The effect of class a scavenger receptor deficiency in bone.
- Transactivation of the Parathyroid hormone promoter by specificity proteins and the nuclear factor Y complex.
- Suppression of the human Parathyroid hormone promoter by vitamin D involves displacement of NF-Y binding to the vitamin D response element.
- Contrasting mammalian Parathyroid hormone (PTH) promoters: nuclear factor-Y binds to a deoxyribonucleic acid element unique to the human PTH promoter and acts as a tra...
- Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal Disease.
- Sp3/Sp1 in the Parathyroid gland: identification of an Sp1 deoxyribonucleic acid element in the Parathyroid hormone promoter.
- Bone biopsy: indications, techniques, and complications.
- Pth 1-84, Pth fragments and bone turnover.
- Administration of PTH-(7-84) antagonizes the effects of PTH-(1-84) on bone in rats with moderate renal Failure.
- Parathyroid hormone type 1 receptor and human osteoclasts.
- Update on vitamin D and its newer analogues: actions and rationale for treatment in Chronic renal failure.
- Zinc nutritional status modifies Renal osteodystrophy in uremic rats.
- Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients.
- Hypercalcemia and human nature.
- Isolation of genomic DNA sequences that bind vitamin D receptor complexes.
- Evidence of functional vitamin D receptors in rat hippocampus.
- Parathyroid hormone/Parathyroid hormone-related peptide type 1 receptor in human bone.
- Hyperphosphatemia: pharmacologic intervention yesterday, today and tomorrow.
- Characterization of vitamin D receptor immunoreactivity in human bone cells.
- Short-term administration of the bisphosphonate ibandronate increases bone volume and prevents hyperparathyroid bone changes in mild experimental renal Failure.
- Molecular bone morphometry.
- Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation.
- High prevalence of low bone turnover and occurrence of osteomalacia after Kidney transplantation.
- Vitamin D receptor interactions with positive and negative DNA response elements: an interference footprint comparison.
- The role of bone biopsy in clinical practice and research.
- Understanding and managing hyperphosphatemia in patients with Chronic renal disease.
- Calcific uremic arteriolopathy in association with low turnover uremic bone Disease.
- Intermittent and continuous administration of the bisphosphonate ibandronate in ovariohysterectomized beagle dogs: effects on bone morphometry and mineral properties.
- 22-oxacalcitriol suppresses secondary Hyperparathyroidism without inducing low bone turnover in dogs with renal failure.
- The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats.
- Pathogenesis and histology of Renal osteodystrophy.
- Selectivity of a C-terminal peptide antiserum for different DNA-binding states of the vitamin D receptor.
- Calcitonin alters bone quality in beagle dogs.
- Moderately high consumption of ethanol suppresses bone resorption in ovariectomized but not in sexually intact adult female rats.
- Role of cytokines in Renal osteodystrophy.
- Systemic osteopenia and mineralization defect in patients with ankylosing spondylitis.
- Secondary Hyperparathyroidism and vitamin D receptor binding to vitamin D response elements in rats with incipient renal failure.
- Calcitonin prevents bone loss but decreases osteoblastic activity in ovariohysterectomized beagle dogs.
- Trends in Renal osteodystrophy: a survey from 1983 to 1995 in a total of 2248 patients.
- Bone resorption and mRNA expression of IL-6 and IL-6 receptor in patients with Renal osteodystrophy.
- Characterization of a response element in the 5'-flanking region of the avian (chicken) PTH gene that mediates negative regulation of gene transcription by 1,25-dihydr...
- Renal bone Disease--an ongoing challenge to the nephrologist.
- Dialysis: current status, contemporary limitations and future challenges.
- Peritonitis due to Exophiala jeanselmei in a patient undergoing continuous ambulatory peritoneal dialysis.
- Oncogenic osteomalacia associated with metastatic prostate Carcinoma: case report and review of the literature.
- Long-term effect of oral calcitriol pulse therapy on bone in hemodialysis patients.
- Animal models for the study of bone loss after cessation of ovarian function.
- Histomorphometric analysis of tricalcium phosphate ceramic implanted into turkeys.
- Structural and cellular assessment of bone quality of proximal femur.
- Development and characterization of a polyclonal antiserum-based radioimmunoassay for dog osteocalcin.
- A new bisphosphonate, BM 21.0955, prevents bone loss associated with cessation of ovarian function in experimental dogs.
- Isolation and complete amino acid sequence of osteocalcin from canine bone.
- The role of bone biopsy in the management of patients with Renal osteodystrophy.
- Evidence for abnormal calcium homeostasis in patients with adynamic bone Disease.
- Calcitriol pulse therapy in patients with end-stage renal Failure.
- Prevention of cancellous bone loss but persistence of renal bone disease despite normal 1,25 vitamin D levels two years after Kidney transplantation.
- Predictive value of serum parathyroid hormone levels for bone turnover in patients on Chronic maintenance dialysis.
- Alkaline phosphatase bone isoenzyme activity in serum in various degrees of micromorphometrically assessed Renal osteopathy.
- Effects of 6 months therapy with 1,25 (OH)2D3 on bone Disease of dialysis patients.
- Long-term effects of 1,25(OH)2D3 on clinical and biochemical derangements of divalent ions in dialysis patients.
- Effects of long-term infusion of physiologic doses of 1-34 PTH on bone.
- A program package for quantitative analysis of histologic structure and remodeling dynamics of bone.
- Current status of the use of 1,25(OH)2D3 in the management of Renal osteodystrophy.
- The role of vitamin D metabolites in the management of bone abnormalities in renal Disease.
- 24R,25-Dihydroxyvitamin D3 and 1 alpha,25-dihydroxyvitamin D3 are both indispensable for calcium and phosphorus homeostasis.
- Effects of long-term therapy with calcitriol in patients with moderate renal Failure.
- Quantitative bone histology in 84 normal American subjects. Micromorphometric analysis and evaluation of variance in iliac bone.
- A new semiautomatic method for quantitative static and dynamic bone histology.
- Factors influencing the intrusion of methylmethacrylate into human tibiae.
- Recurrent fractures, hypophosphatemia, and Renal insufficiency in an elderly woman.
- Iga nephropathy: presentation, clinical course, and prognosis in children and adults.
- The use of deferoxamine in the management of aluminium accumulation in bone in patients with renal Failure.
- Comparison of different bone-biopsy techniques for qualitative and quantitative diagnosis of metabolic bone Diseases.
- Plasma levels of bone Gla-protein reflect bone formation in patients on Chronic maintenance dialysis.
- Effects and interactions of 24R,25(OH)2D3 and 1,25(OH)2D3 on bone.
- Abnormal bone histology in idiopathic hypercalciuria.
- Metabolic bone Disease in patients on maintenance hemodialysis.
- Skeletal abnormalities in Chronic renal insufficiency before and during maintenance hemodialysis.
- [Skeletal histology in uremic osteodystrophy following increase of dialysate calcium concentration to 3,75 mval-1 (preliminary report)].
- [Conservative and surgical therapy of Goodpasture''s syndrome].
- [Some topical problems of subtotal Parathyroidectomy in patients on haemodialysis].
Schools
JohannWolfgangGoetheUniversitaet Frankfurt Fachbereich Humanmedizin
Procedures Preformed
- Biopsy
- Central Line Insertion (for Chemotherapy)
- Dialysis Access Procedures
- Embolectomy, Thrombectomy, or Vessel Exploration
- View All
Conditions Treated
- Abdominal Pain
- Anemia
- Breast Cancer
- Carcinoma in Situ
- View All
Doctors Specialties
- General Surgery
- Nephrology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Pathway X Ind Direct Access KY
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Cigna HMO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Choice Care PPO
- Preferred PPO
- MultiPlan PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- CMS Meaningful Use Stage 1 Certification
- Elected Member
- Whos Who in Medicine and Healthcare
Hospital
-
University of Kentucky Albert B. Chandler Hospital
Drug Facts
| NPI NUMBER | 1174618326 | |
| NPPES Provider LastName | MALLUCHE | |
| NPPES Provider FirstName | HARTMUT | |
| NPPES Provider ZIPCode | 405360001 | |
| NPPES Provider State | KY | |
| Specialty Description | Nephrology | |
| Total Claim Count | 103.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1174618326 |
| Last Name Of The Provider | MALLUCHE |
| First Name Of The Provider | HARTMUT |
| View All |
Similar Doctors
|
Dr. Malay B. Shah, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan D. Wilkerson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Monica S. Hall, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katrina A. Winkler, MD
This Doctor is OpenDoctor Recommended.
|